IPQ Inside the global regulatory dialogue

Manufacturing, Impurities, and Characterization Methods Are Key Regulatory Focal Points for Peptides and Oligonucleotides

Aug 9th, 2021

Please Log in to print the full article

The manufacturing process, the control of impurities – in the starting materials, the API and the drug product – and the analytical methods for characterization are focal...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications